Company: ALGN
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001097149-25-000079
Chunk: 223

Company: ALIGN TECHNOLOGY INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 2
Chunk 223
---
 Specifically, we are managing financial impacts by implementing strategic product innovations, introductions and pricing actions, implementing cost saving measures, and evaluating hiring needs.

Further discussion of the impact of these challenges on our business may be found in Part II, Item 1A “Risk Factors.”

Key Financial and Operating Metrics

We measure our performance against the foregoing strategic priorities by the achievement of key financial and operating metrics. For the three months ended September 30, 2025, our business operations reflect the following:

•Revenues of $996 million, an increase of 1.8% year-over-year;

•Clear Aligner revenues of $806 million, an increase of 2.4% year-over-year; 

•Clear Aligner case volume increased 4.9% year-over-year and Clear Aligner case volume for teens and growing patients increased from 236.3 thousand shipments to 256.0 thousand or 8.3% year-over-year; 

•Imaging Systems and CAD/CAM services revenues of $190 million, a decrease of 0.6% year-over-year;

•Income from operations of $96 million and operating margin of 9.7%;

•Effective tax rate of 40.1%;

•Net income of $57 million with diluted net income per share of $0.78;

•Cash and cash equivalents of $1,005 million as of September 30, 2025;

•Cash provided by operating activities of $189 million;

•Capital expenditures of $20 million, primarily related to investments in our manufacturing capacity and facilities; and

•Number of employees was 21,065 as of September 30, 2025, a decrease of 2.9% year-over-year. 

Other Statistical Data and Trends

•As of September 30, 2025, approximately 21 million people worldwide have been treated with our Invisalign system. 

•For the third quarter of 2025, the total number of Invisalign trained doctors cases were shipped to (doctor submitters) was 88.2 thousand compared to 87.4 thousand in the third quarter of 2024, a 0.9% increase. 

30 

•The total utilization rate in the third quarter of 2025 increased to 7.3 cases per doctor compared to 7.1 cases per doctor in the third quarter of 2024.

•Clear aligner revenue per case shipment (clear aligner revenues divided by